Drug Trial Radar · NCT05331859
Topical Insulin Versus Autologous Serum After Corneal Surgeries
Last checked: Nov 19, 2026Latest source record: Apr 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
250
Planned (sponsor's estimate)
Start
May 2022
Primary completion
Aug 2022
Study completion Sep 2022
Sponsor
- Lead sponsor
- Benha UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the study is to test whether use of topical insulin or autologous serum eye-drops can promote corneal epithelial healing following photorefractive keratectomy (PRK).
Conditions
- Corneal Epithelial Wound
Interventions
InsulinDrug
Topical insulin drops will be prepared by diluting 1 unit of rapid-acting insulin per 1 mL of an artificial tear with a propylene glycol base. Drops will be preserved at low temperature (2ºC) and applied four times a day.
autologous serum (AS)Drug
Whole blood (20 ml) wll be procured by venipuncture, centrifuged at 1,500 revolutions per minute (relative centrifugal force of 25.15 × g) for 10 minutes. AS drops will be carefully prepared under a laminar airflow cabinet, and diluted with artificial tears (Systane ultra; Alcon) to 20%. AS drops will be prepared on the day of surgery and patients will be asked to keep AS drops refrigerated at about 4C.
conventionalDrug
Topical moxifloxacin 0.5% (Vigamox; Alcon Laboratories) four times per day, artificial tears (Systane ultra; Alcon) every two hours, Dexamethasone 0.1% (Maxidex; Alcon Laboratories) four times daily for one month then fluorometholone 0.1% (Efemyo; Orchidia Laboratories) four times daily for another two to four weeks depending on refraction and haze level.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Duration for the corneal surface to completely re-epithelialize.Time frame: up to 6 weeks
- Grade of postoperative corneal hazeTime frame: 6 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Benha University
Banhā, Egypt
Ebsar Eye Centre
Banhā, Kalyobeya, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.